These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28228373)

  • 21. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
    Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery.
    Gower EW; Lindsley K; Tulenko SE; Nanji AA; Leyngold I; McDonnell PJ
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006364. PubMed ID: 28192644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
    Parravano M; Menchini F; Virgili G
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007419. PubMed ID: 19821414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.
    Jenkins AJ; Grant MB; Busik JV
    Diabetologia; 2022 Apr; 65(4):587-603. PubMed ID: 35149880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Head-to-head comparison of fibrates versus statins for elevation of circulating adiponectin concentrations: a systematic review and meta-analysis.
    Sahebkar A
    Metabolism; 2013 Dec; 62(12):1876-85. PubMed ID: 24095632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema.
    Sahoo S; Barua A; Myint KT; Haq A; Abas AB; Nair NS
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD010009. PubMed ID: 25686158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
    Lewicki M; Ng I; Schneider AG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010480. PubMed ID: 25758322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol.
    Bascaran C; Mwangi N; D'Esposito F; Cleland C; Gordon I; Ulloa JAL; Maswadi R; Mdala S; Ramke J; Evans JR; Burton M
    Syst Rev; 2021 Jan; 10(1):27. PubMed ID: 33446272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.
    Juthani VV; Clearfield E; Chuck RS
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010516. PubMed ID: 28670710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Lindsley K
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006539. PubMed ID: 28122126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
    Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(5):1019-21. PubMed ID: 16188392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations.
    Hamilton-Craig I; Kostner KM; Woodhouse S; Colquhoun D
    Int J Evid Based Healthc; 2012 Sep; 10(3):181-90. PubMed ID: 22925614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical cyclosporine for atopic keratoconjunctivitis.
    González-López JJ; López-Alcalde J; Morcillo Laiz R; Fernández Buenaga R; Rebolleda Fernández G
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009078. PubMed ID: 22972132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-lowering agents for nephrotic syndrome.
    Kong X; Yuan H; Fan J; Li Z; Wu T; Jiang L
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005425. PubMed ID: 24327265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Smith JM; Steel DH
    Cochrane Database Syst Rev; 2011 May; (5):CD008214. PubMed ID: 21563165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis.
    Cheloni R; Gandolfi SA; Signorelli C; Odone A
    BMJ Open; 2019 Mar; 9(3):e022188. PubMed ID: 30833309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tailored Communication Within Mobile Apps for Diabetes Self-Management: A Systematic Review.
    Holmen H; Wahl AK; Cvancarova Småstuen M; Ribu L
    J Med Internet Res; 2017 Jun; 19(6):e227. PubMed ID: 28645890
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.